COVID-19 treatment
- Hyderabad
Hyderabad: Sunshine Hospitals to refund Rs 8.70L to customer for COVID treatment
Hyderabad: A local consumer court on February 22 ordered Sunshine Hospitals, a unit of Sarvejana Healthcare to pay a refund of Rs 8,73,943 for exorbitantly charging a Kulsumpura resident for COVID-19 treatment.…
- Hyderabad
Hyd-based Biophore seeks DCGI approval for use of Aviptadil in COVID treatment
Hyderabad: Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of…
- Hyderabad
Ensure refund of excess fees collected by hospitals: HC to Telangana govt
Hyderabad: Telangana high court has directed state government to ensure the refund of excess fees collected by private hospitals for COVID-19 treatment. The court also expressed concern over state government’s failure to…
- India
Govt stops central allocation of Remdesivir to states as supply improves
New Delhi: The Centre has stopped allocation of antiviral drug Remdesivir to states as the supply of the critical medication has surpassed the demand, Union Minister Mansukh L Mandaviya said on Saturday. “Now…
- Telangana
COVID dawakhana inaugurated in Narayanpet; more to be opened soon
Hyderabad: In a bid to provide health services to patients battling COVID-19 in rural areas, Telangana Information Technology Association (TITA) took an initiative to set up COVID dawakhanas across the state. The…
- Telangana
Telangana: Private hospitals overcharging? Lodge complaint on this number
Hyderabad: Health authorities in Telangana on Tuesday cautioned people to be wary of private hospitals overcharging patients for providing COVID-19 treatment. Addressing a press conference here, Director of Public Health and Family…
- India
India drops plasma therapy from COVID-19 management guidelines
New Delhi: The government on Monday revised the clinical guidance for COVID-19 treatment, dropping the off-label use of convalescent plasma as it was found not beneficial in reducing the progression to severe…
- Hyderabad
Dr Reddy’s to manufacture Baricitinib drug for Covid treatment
Hyderabad: Pharma major Dr. Reddy’s Laboratories Ltd on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of Baricitinib…
